AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches
SAN DIEGO, April 23, 2026 /PRNewswire/ — Abbisko Therapeutics (HKEX: 02256) announced…
April 23, 2026
Beijing InfoComm China 2026 Defies Economic Headwinds with over 300 Key Exhibitors and Brands with World-wide Footprints Converging to Map AI-Driven AV Transformation Amid Market Consolidation
BEIJING, April 23, 2026 /PRNewswire/ — Beijing InfoComm China 2026 concluded at…